74 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 74 of 74 clinical reviews.
A detailed guide to Aetna (CVS Health) coverage for rapamycin (sirolimus), including formulary tier, prior authorization criteria, step therapy requirements, appeal strategies, and cash-pay alternatives.
Find out whether Anthem (Elevance Health) covers rapamycin (sirolimus), including formulary tier, prior authorization requirements, step therapy, appeal options, and cost-saving strategies.
A complete guide to Blue Cross Blue Shield (Federated) coverage of rapamycin (sirolimus), including formulary tier, prior authorization criteria, step therapy requirements, appeal strategies, and cash-pay alternatives.
A complete guide to Cigna coverage, prior authorization criteria, formulary tier, step therapy, appeals, and out-of-pocket costs for sirolimus (rapamycin).
A detailed look at Kaiser Permanente's formulary status, prior authorization requirements, step therapy rules, and appeal options for rapamycin (sirolimus), including cash-pay alternatives and clinical context.
A clinical guide to TRICARE coverage, prior authorization, formulary tier, step therapy, and appeal options for rapamycin (sirolimus) in 2025.
A clinical guide to UnitedHealthcare coverage, prior authorization, formulary tier, step therapy, and appeal strategies for rapamycin (sirolimus), including off-label longevity use.
A clinical guide to obtaining a rapamycin (sirolimus) prescription in Arizona, including telehealth options, 503A compounding pharmacies, required labs, and cost expectations.
A complete guide to obtaining a rapamycin (sirolimus) prescription in Arkansas, including telehealth options, 503A compounding pharmacies, required labs, and prior authorization steps.
A clinical guide to obtaining rapamycin (sirolimus) in California through telehealth, in-person prescribers, and 503A compounding pharmacies, including required labs, prior authorization, and cost details.
A complete guide to obtaining a rapamycin (sirolimus) prescription in Colorado via telehealth, 503A compounding pharmacies, and in-person providers.
A complete guide to obtaining rapamycin (sirolimus) in Connecticut via telehealth, in-person prescribers, 503A compounding pharmacies, required labs, prior authorization, and off-label longevity dosing protocols.
A clinical guide to obtaining rapamycin (sirolimus) in Delaware via telehealth, in-person prescribers, and 503A compounding pharmacies, including labs, dosing, and prior authorization steps.
A clinical guide to obtaining rapamycin (sirolimus) in Georgia, covering telehealth prescribing, 503A compounding pharmacies, required labs, prior authorization, and pharmacy shipping rules.
A complete guide to obtaining a rapamycin (sirolimus) prescription in Iowa, including telehealth options, pharmacy access, required labs, and prior authorization details.
A clinical guide to obtaining rapamycin (sirolimus) in Kentucky via telehealth, 503A compounding pharmacies, and in-person prescribers, including labs, costs, and prior authorization.
A complete guide to obtaining a rapamycin (sirolimus) prescription in Massachusetts, including telehealth options, 503A compounding pharmacies, required labs, and prior authorization steps.
A step-by-step guide to obtaining a rapamycin (sirolimus) prescription in Missouri, including telehealth options, 503A compounding pharmacies, required labs, and cost details.
A complete guide to obtaining a rapamycin (sirolimus) prescription in Nebraska, including telehealth options, 503A compounding pharmacies, required labs, and costs.
A clinical guide to obtaining a rapamycin (sirolimus) prescription in New York, covering telehealth options, 503A compounding pharmacies, required labs, prior authorization, and costs.
A complete guide to obtaining a rapamycin (sirolimus) prescription in Ohio, including telehealth options, 503A compounding pharmacies, required labs, and cost considerations.
A complete guide to obtaining rapamycin (sirolimus) in Oklahoma via telehealth, compounding pharmacies, and in-state prescribers for off-label longevity use.
Sirolimus is prescription-only. Learn the safe, plan-specific way Tennessee residents can verify access and why online longevity protocols are not approved directions.
A guide to obtaining rapamycin (sirolimus) in Vermont via telehealth, in-person prescribers, and 503A compounding pharmacies, including labs, costs, and prior authorization steps.
Evidence-based guide to sirolimus dosing in adolescents aged 12, 17, covering FDA-approved transplant indications, weight-based calculations, trough monitoring, and off-label considerations.
Evidence-based monitoring guide for rapamycin (sirolimus) in adolescents aged 12 to 17, covering trough levels, growth tracking, metabolic labs, immune function, and mental health screening.
Complete guide to rapamycin (sirolimus) dosing for adults aged 30 to 49, covering off-label longevity protocols, transplant dosing, monitoring requirements, and safety considerations.
A clinician-grade guide to every major rapamycin (sirolimus) drug-drug interaction, including CYP3A4 inhibitors, inducers, calcineurin inhibitors, and off-label longevity dosing considerations.
Current rapamycin (sirolimus) prices in Hawaii for 2026. Compare retail, compounded, and discount options. Learn about Medicaid coverage, insurance, telehealth access, and how to pay the least.
What rapamycin (sirolimus) costs in Illinois in 2026, including cash-pay pricing, Medicaid coverage, compounded options, insurance tips, and discount programs.
Current rapamycin (sirolimus) prices in New York for 2026, including cash-pay, compounded, Medicaid, and insurance coverage options with discount programs.
Current rapamycin (sirolimus) prices in North Carolina for 2026, including cash-pay, compounded, insurance coverage, Medicaid status, and discount programs.
Current rapamycin (sirolimus) pricing in Oklahoma for 2026, including cash-pay costs, Medicaid coverage status, compounded options, telehealth access, and discount programs.
What rapamycin (sirolimus) costs in Oregon in 2026, including cash-pay pricing, Medicaid coverage, compounded options, and discount programs for transplant and off-label longevity use.
What rapamycin (sirolimus) costs in Texas in 2026, including cash-pay pharmacy prices, compounded sirolimus options, Medicaid coverage, insurance, telehealth access, and discount programs.
Current rapamycin (sirolimus) pricing in Utah for 2026, including cash-pay pharmacy costs, Medicaid coverage status, compounded sirolimus from 503A pharmacies, insurance options, and telehealth access.
What rapamycin (sirolimus) costs in Virginia in 2026, including cash-pay prices, Medicaid coverage, compounded options from 503A pharmacies, insurance details, and discount programs.
How to verify a current sirolimus price in Washington, check Apple Health or other insurance, compare brand and generic forms, and understand the evidence limits for off-label longevity use.
What rapamycin (sirolimus) costs in West Virginia in 2026. Covers retail cash prices, Medicaid status, compounded sirolimus from 503A pharmacies, insurance coverage, telehealth access, and discount programs.
A clinical comparison of sirolimus pricing against everolimus, metformin, and other mTOR-adjacent longevity compounds, with evidence-based guidance on value per dollar.
Evidence-based guide to rapamycin (sirolimus) dosing in older adults aged 50 to 64, covering off-label longevity protocols, FDA-approved transplant doses, safety monitoring, and age-specific considerations.
Evidence-based guide to rapamycin (sirolimus) dosing considerations for adults aged 18-29, covering off-label longevity protocols, fertility risks, immune effects, and monitoring requirements.
A guide to sirolimus dose adjustments in hepatic impairment, covering PK changes, FDA labeling, clinical monitoring, and emerging longevity-use data.
A guide to sirolimus dosing adjustments, pharmacokinetics, and monitoring in patients with chronic kidney disease, transplant nephropathy, and off-label longevity use.
Comprehensive guide to rapamycin (sirolimus) food and supplement interactions, covering grapefruit, St. John's Wort, fat-soluble vitamins, and key pharmacokinetic data with primary-source citations.
A clinical deep dive into rapamycin's emerging formulations, next-generation rapalogs, selective mTORC1 inhibitors, and longevity-focused pipeline trials currently in development.
A guide to rapamycin (sirolimus) dosing in adults aged 65 and older, covering transplant protocols, off-label longevity use, renal adjustment, drug interactions, and the PEARL trial evidence.
A comprehensive clinical guide to monitoring rapamycin (sirolimus) in adults aged 65 and older, covering trough levels, renal function, drug interactions, falls risk, and deprescribing considerations.
A clinical deep-dive into how sirolimus is manufactured, its supply chain vulnerabilities, FDA shortage records, and what prescribers and patients should know about current availability.
A physician-level breakdown of how rapamycin (sirolimus) works, from FKBP12 binding through mTORC1 inhibition to downstream effects on autophagy, senescence, and immune modulation.
Evidence-based guidance on what to do when you miss a dose of rapamycin (sirolimus), including timing rules for weekly off-label longevity dosing and daily transplant regimens.
A complete clinical guide to monitoring sirolimus (rapamycin) in adults aged 30-49, covering lab panels, dosing schedules, safety thresholds, and what the PEARL trial and transplant guidelines say about off-label longevity use.
A complete clinical guide to rapamycin (sirolimus) monitoring for adults aged 50 to 64, covering trough levels, lab schedules, drug interactions, and age-specific safety considerations backed by trial evidence.
A guide to sirolimus blood-level testing, lab monitoring schedules, fertility considerations, and safety checkpoints for healthy adults aged 18 to 29 using rapamycin off-label.
Complete rapamycin (sirolimus) monitoring schedule covering blood trough levels, lipid panels, CBC, renal function, glucose, and imaging exams for both transplant and off-label longevity use.
A clinical review of rapamycin (sirolimus) off-label applications, from longevity and immune aging to skin rejuvenation, with evidence grading for each use case.
Evidence-based guide to sirolimus overdose recognition, toxicity management, and clinical recovery. Covers accidental excess dosing in transplant and off-label longevity contexts with FDA and PubMed-cited protocols.
A clinician-grade review of the sirolimus patent history, generic availability, and what the expiration of key patents means for off-label longevity prescribing and cost.
Evidence-based guide to sirolimus (rapamycin) dosing in children under 12, covering weight-based protocols, therapeutic drug monitoring, off-label indications, and safety considerations.
Evidence-based guide to sirolimus monitoring in pediatric patients under 12, covering trough levels, renal panels, growth tracking, CBC intervals, and dose adjustments by weight.
Showing the first 60 matches. Use search or filters to narrow the library.